US › Healthcare

Conduit Pharmaceuticals Inc. (CDT)

US · Healthcare · Biotechnology

$0.23+12.44%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$750.2M

Revenue YoY

+11.6%

Net profit

$68.5M

EPS

$-8.71

Net margin

9.1%

Key statistics

Market cap

$29,108

P/E

0.0

Forward P/E

0.0

P/B

0.02

Book value

$4,084.02

EPS (TTM)

$90,812.50

52-week high

$28,125.00

52-week low

$0.70

50-day MA

$35.34

200-day MA

$2,277.03

Beta

1.56

Shareholding

Insiders

29.61%

Institutions

0.06%

Largest institutional holders

Fund	Stake
Financial Management Professionals Inc	0.10%
Tower Research Capital LLC	0.09%
Morgan Stanley - Brokerage Accounts	0.00%
Apollon Wealth Management, LLC	0.00%
SBI Securities Co Ltd	0.00%
Virtu Financial LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Conduit Pharmaceuticals Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.